KELADA PHARMACHEM LIMITED -  

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2015-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 5
As coordinator: 1
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0.25*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 7.573.014 1.222.815 1
2021 257.600 0 110.400 1
2019 0 607.200 220.800 1
2016 0 774.000 180.000 1
2015 0 234.000 72.000 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ARISTOTELIAN UNIVERSITY OF THESSALONIKI1
BENKEI1
CIRCA GROUP AS1
CONSIGLIO NAZIONALE DELLE RICERCHE1
ECOLOGIC INSTITUT GEMEINNUETZIGE1
LEUPHANA UNIVERSITAT LUNEBURG1
MASARYKOVA UNIVERZITA1
ORION OYJ1
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU1
STICHTING RADBOUD UNIVERSITEIT1
UNIVERSIDAD DE CORDOBA1
UNIVERSITa DEGLI STUDI DI NAPOLI 'FEDERICO II'1
UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II1
UNIVERSITAT LINZ1
UNIVERSITEIT GENT1
UNIVERSITY OF HELSINKI1
UNIVERSITY OF YORK1

Constancy:

Total number of partners: 17
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 17
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2022-06-01Transforming into a sustainable European pharmaceutical sector TransPharmparticipant7.573.01411
2021-07-01Proof of Concept for a Platform for the Fast and General Elucidation of the Interaction Between Proteins and RNA ProteRNAcoordinator257.6003
2019-04-01Green Enantioselective Halogenation for Drug Discovery and Manufacture GreenX4Drugparticipant607.2003
2016-03-01New Quaternary Ammonium Salts for use in Drug Manufacture QuatSaltsparticipant774.0003
2015-06-01Chemo-Enzymatic Manufacturing Routes to High- Value compounds ChemoEnzparticipant234.0002